vs
Harmony Biosciences Holdings, Inc.（HRMY）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Harmony Biosciences Holdings, Inc.的季度营收约是Rocket Lab Corp的1.4倍（$243.8M vs $179.7M），Harmony Biosciences Holdings, Inc.净利率更高（9.2% vs -29.5%，领先38.7%），Rocket Lab Corp同比增速更快（35.7% vs 21.1%），Harmony Biosciences Holdings, Inc.自由现金流更多（$126.0M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 25.6%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
HRMY vs RKLB — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $179.7M |
| 净利润 | $22.5M | $-52.9M |
| 毛利率 | 71.9% | 38.0% |
| 营业利润率 | 15.8% | -28.4% |
| 净利率 | 9.2% | -29.5% |
| 营收同比 | 21.1% | 35.7% |
| 净利润同比 | -54.6% | -1.1% |
| 每股收益（稀释后） | $0.38 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $243.8M | $179.7M | ||
| Q3 25 | $239.5M | $155.1M | ||
| Q2 25 | $200.5M | $144.5M | ||
| Q1 25 | $184.7M | $122.6M | ||
| Q4 24 | $201.3M | $132.4M | ||
| Q3 24 | $186.0M | $104.8M | ||
| Q2 24 | $172.8M | $106.3M | ||
| Q1 24 | $154.6M | $92.8M |
| Q4 25 | $22.5M | $-52.9M | ||
| Q3 25 | $50.9M | $-18.3M | ||
| Q2 25 | $39.8M | $-66.4M | ||
| Q1 25 | $45.6M | $-60.6M | ||
| Q4 24 | $49.5M | $-52.3M | ||
| Q3 24 | $46.1M | $-51.9M | ||
| Q2 24 | $11.6M | $-41.6M | ||
| Q1 24 | $38.3M | $-44.3M |
| Q4 25 | 71.9% | 38.0% | ||
| Q3 25 | 75.1% | 37.0% | ||
| Q2 25 | 81.0% | 32.1% | ||
| Q1 25 | 82.7% | 28.8% | ||
| Q4 24 | 73.0% | 27.8% | ||
| Q3 24 | 77.0% | 26.7% | ||
| Q2 24 | 81.4% | 25.6% | ||
| Q1 24 | 82.2% | 26.1% |
| Q4 25 | 15.8% | -28.4% | ||
| Q3 25 | 27.3% | -38.0% | ||
| Q2 25 | 24.0% | -41.3% | ||
| Q1 25 | 30.4% | -48.3% | ||
| Q4 24 | 27.7% | -38.9% | ||
| Q3 24 | 33.2% | -49.5% | ||
| Q2 24 | 12.4% | -40.7% | ||
| Q1 24 | 33.7% | -46.4% |
| Q4 25 | 9.2% | -29.5% | ||
| Q3 25 | 21.2% | -11.8% | ||
| Q2 25 | 19.8% | -46.0% | ||
| Q1 25 | 24.7% | -49.5% | ||
| Q4 24 | 24.6% | -39.5% | ||
| Q3 24 | 24.8% | -49.6% | ||
| Q2 24 | 6.7% | -39.2% | ||
| Q1 24 | 24.8% | -47.7% |
| Q4 25 | $0.38 | $-0.09 | ||
| Q3 25 | $0.87 | $-0.03 | ||
| Q2 25 | $0.68 | $-0.13 | ||
| Q1 25 | $0.78 | $-0.12 | ||
| Q4 24 | $0.85 | $-0.11 | ||
| Q3 24 | $0.79 | $-0.10 | ||
| Q2 24 | $0.20 | $-0.08 | ||
| Q1 24 | $0.67 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $1.0B |
| 总债务越低越好 | $163.7M | $152.4M |
| 股东权益账面价值 | $870.2M | $1.7B |
| 总资产 | $1.3B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.09× |
8季度趋势，按日历期对齐
| Q4 25 | $775.3M | $1.0B | ||
| Q3 25 | $672.6M | $976.7M | ||
| Q2 25 | $565.3M | $688.1M | ||
| Q1 25 | $507.0M | $428.4M | ||
| Q4 24 | $467.2M | $419.0M | ||
| Q3 24 | $410.5M | $442.4M | ||
| Q2 24 | $346.9M | $496.8M | ||
| Q1 24 | $372.4M | $492.5M |
| Q4 25 | $163.7M | $152.4M | ||
| Q3 25 | $168.5M | $347.0M | ||
| Q2 25 | $172.1M | $346.5M | ||
| Q1 25 | $175.7M | $345.9M | ||
| Q4 24 | $179.3M | $345.4M | ||
| Q3 24 | $182.8M | $61.2M | ||
| Q2 24 | $186.4M | $64.2M | ||
| Q1 24 | $190.0M | $66.8M |
| Q4 25 | $870.2M | $1.7B | ||
| Q3 25 | $835.1M | $1.3B | ||
| Q2 25 | $773.1M | $688.5M | ||
| Q1 25 | $720.5M | $431.3M | ||
| Q4 24 | $659.2M | $382.5M | ||
| Q3 24 | $596.8M | $419.8M | ||
| Q2 24 | $538.6M | $455.2M | ||
| Q1 24 | $515.4M | $478.9M |
| Q4 25 | $1.3B | $2.3B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.1B | $1.6B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $999.2M | $1.2B | ||
| Q3 24 | $928.1M | $1.2B | ||
| Q2 24 | $858.4M | $1.2B | ||
| Q1 24 | $847.0M | $1.2B |
| Q4 25 | 0.19× | 0.09× | ||
| Q3 25 | 0.20× | 0.27× | ||
| Q2 25 | 0.22× | 0.50× | ||
| Q1 25 | 0.24× | 0.80× | ||
| Q4 24 | 0.27× | 0.90× | ||
| Q3 24 | 0.31× | 0.15× | ||
| Q2 24 | 0.35× | 0.14× | ||
| Q1 24 | 0.37× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $126.0M | $-114.2M |
| 自由现金流率自由现金流/营收 | 51.7% | -63.6% |
| 资本支出强度资本支出/营收 | 0.0% | 27.6% |
| 现金转化率经营现金流/净利润 | 5.61× | — |
| 过去12个月自由现金流最近4个季度 | $347.9M | $-321.8M |
8季度趋势，按日历期对齐
| Q4 25 | $126.2M | $-64.5M | ||
| Q3 25 | $108.7M | $-23.5M | ||
| Q2 25 | $79.3M | $-23.2M | ||
| Q1 25 | $34.0M | $-54.2M | ||
| Q4 24 | $75.6M | $-2.4M | ||
| Q3 24 | $70.5M | $-30.9M | ||
| Q2 24 | $42.6M | $-13.0M | ||
| Q1 24 | $31.1M | $-2.6M |
| Q4 25 | $126.0M | $-114.2M | ||
| Q3 25 | $108.7M | $-69.4M | ||
| Q2 25 | $79.3M | $-55.3M | ||
| Q1 25 | $33.9M | $-82.9M | ||
| Q4 24 | $75.0M | $-23.9M | ||
| Q3 24 | $70.5M | $-41.9M | ||
| Q2 24 | $42.0M | $-28.3M | ||
| Q1 24 | $31.1M | $-21.8M |
| Q4 25 | 51.7% | -63.6% | ||
| Q3 25 | 45.4% | -44.8% | ||
| Q2 25 | 39.6% | -38.3% | ||
| Q1 25 | 18.3% | -67.6% | ||
| Q4 24 | 37.3% | -18.1% | ||
| Q3 24 | 37.9% | -40.0% | ||
| Q2 24 | 24.3% | -26.7% | ||
| Q1 24 | 20.1% | -23.5% |
| Q4 25 | 0.0% | 27.6% | ||
| Q3 25 | 0.0% | 29.6% | ||
| Q2 25 | 0.0% | 22.2% | ||
| Q1 25 | 0.1% | 23.4% | ||
| Q4 24 | 0.3% | 16.3% | ||
| Q3 24 | 0.0% | 10.5% | ||
| Q2 24 | 0.4% | 14.4% | ||
| Q1 24 | 0.0% | 20.7% |
| Q4 25 | 5.61× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 1.53× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | 0.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRMY
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
